Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Archinoetics was a neurotechnology company based in Honolulu, Hawaii, that specialized in the development of advanced biosensors and human-computer interface systems. The company focused on creating wearable devices for real-time physiological monitoring, particularly EEG-based systems designed to assess cognitive state and detect traumatic brain injury. Their technology was extensively utilized in military and research applications, often supported by DARPA, to monitor human performance in high-stress environments. Archinoetics developed sophisticated signal processing algorithms to translate complex neurological data into actionable insights for clinicians and researchers. In 2012, the company was acquired by Cerora, which integrated Archinoetics' hardware and sensor capabilities into its own brain health diagnostic platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Archinoetics.